The Asset Performance Team leader at BSRIA discusses her recent work testing isolation room design to enable such spaces’ optimal use for both infectious and immunocompromised patients.
Blanca Beato-Arribas, the Asset Performance Team leader at BSRIA, the ISO 9001-registered test, instruments, research, and consultancy organisation, describes her recent work testing the design of isolation rooms that allow the room to be optimally used for both infectious and immunocompromised patients. With pressure differentials the determining factor when controlling infection between an isolation suite and the rest of the hospital, she explains that air permeability levels within the suite should be as low as possible.
The design of isolation rooms intended for the prevention of airborne transmitted diseases is typically dependent on the category level of the pathogens they aim to contain, and whether the patient is infectious or at risk of infection. Isolation suites designed to protect against airborne infections for pathogens in categories 1 to 3 may consist of several adjoining spaces, e.g. an entrance lobby, patient’s room, and en suite bathroom. The ventilation strategies used to protect against infection transmission of airborne pathogens can be divided into two groups – those used to prevent transmission between the suite and the rest of the hospital, and those used within the isolation suite itself. The latter include dilution ventilation (where the concentration of a pathogen is diluted, reducing the likelihood of a person being exposed to an infectious dose), and good mixing, (where the concentration of a pathogen is diluted to the same level everywhere in a room, avoiding stagnant areas of high contaminant concentration in the room).
Pressure differentials
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.